A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome
- 31 January 1998
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 9 (3), 141-146
- https://doi.org/10.1016/s0924-8579(97)00043-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Azithromycin: the first of the tissue-selective azalidesInternational Journal of Antimicrobial Agents, 1995
- Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysisJAMA, 1995
- Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitisAntimicrobial Agents and Chemotherapy, 1992
- Treatment of acute exacerbations of chronic bronchitis: State of the artAmerican Journal Of Medicine, 1991
- Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumoniaAntimicrobial Agents and Chemotherapy, 1991
- Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1990
- Comparative in vitro activity of the new oral macrolide azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987
- Antibiotics for Exacerbations of Chronic Bronchitis?The Lancet, 1987